This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: The Cleveland Clinic Foundation, Other. Active years: 2022.
Company Filing History:
1 out of 1,071 
1 out of 834,411 Years Active: 2022
Title: Innovations of Inventor Tomasz Herjan
Introduction
Tomasz Herjan is a notable inventor based in Beachwood, OH (US). He has made significant contributions to the field of biomedical research, particularly in the development of transgenic models and therapeutic methods.
Latest Patents
Tomasz Herjan holds 2 patents that showcase his innovative work. His latest patents include "Transgenic mice with inducible neuron-specific inactivation of HuR gene and method of screening." This patent provides non-human transgenic animals that under-express or do not express the Hu Antigen R (HuR) gene in specific neurons. These models are instrumental in screening drugs and therapies, particularly for conditions like ALS. Another significant patent is for "SBE aptamers for treating IL-17a related diseases and conditions." This invention involves compositions and methods that utilize an SBE nucleic acid sequence to target the SEFIR domain of an ACT1 protein, offering potential treatments for IL-17a related diseases.
Career Highlights
Throughout his career, Tomasz has worked with esteemed institutions, including the Cleveland Clinic Foundation. His work has been pivotal in advancing research in neurobiology and therapeutic interventions.
Collaborations
Tomasz has collaborated with notable colleagues such as Xiaoxia Li and Xing Chen, contributing to a rich exchange of ideas and innovations in his field.
Conclusion
Tomasz Herjan's contributions to biomedical research through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and research methodologies.